1. Danilov M.V., Fedorov V.D. Giperplasticheskie i dizontogeneticheskie protsessy kak etiologicheskie faktory khronicheskogo pankreatita // Khirurgiya podzheludochnoi zhelezy. M.: Meditsina, 1995. S. 45-48.
2. Al-Jitawi S.A., Hiarat A.M., Al-Majali S.H. Diffuse myoepithelial hamartoma of the duodenum associated with adenocarcinoma // Clin. Oncol. 1984. № 10. R. 289-293.
3. Armstrong C.P., King P.M., Dixon K.M. The clinical significance of heterotopic pancreas in the gastrointestinal tract // Br. J. Surg. 1981. № 68. R. 384-387.
4. Basili E., Allemand I., Ville E., Laugier R. Lanreotide acetate may cure cystic dystrophy in heterotopic pancreas of the duodenal wall // Gastroenterol. Clin. Biol. 2001. № 25. R. 1108-1111.
5. Bittar I., Cohen Solal J.L., Cabanis P., Hagege H. Cystic dystrophy of an aberrant pancreas. Surgery after failure of medical therapy // Presse Med. 2000. № 29. R. 1118-1120.